Tom Brieva, based in Englishtown, NJ, US, is currently a Vice President, Cell Therapy Process, Analytical, and Technology Development at Resilience, bringing experience from previous roles at Bristol-Myers Squibb acquired Celgene and Celgene. Tom Brieva holds a 2007 - 2007 MiniMBA Certificate in Business Essentials @ Rutgers University. With a robust skill set that includes Public Speaking, Process Improvement, Product Development, Engineering, Leadership and more, Tom Brieva contributes valuable insights to the industry. Tom Brieva has 1 email on RocketReach.